Assessing the benefit-risk balance of drugs. Some lessons from the COVID pandemic

Jean-Luc Cracowski,Mathieu Molimard,Vincent Richard,Matthieu Roustit,Charles Khouri
DOI: https://doi.org/10.1080/14740338.2024.2368811
2024-06-21
Expert Opinion on Drug Safety
Abstract:Introduction Drug efficacy and effectiveness are assessed respectively through clinical trials and pharmaco-epidemiological studies. However, relative and absolute benefits of drugs are distinct measures that must be considered in relation to the baseline risk of disease incidence, complication or progression. On the other hand, adverse drug reactions are independent of the basic risk but depend on the characteristics of the population treated. Given these prerequisites, how can we balance the benefits and risks of drugs?
pharmacology & pharmacy
What problem does this paper attempt to address?